Biogen Netherlands has received marketing authorisation from the UK MHRA for its Skyclarys to treat Friedreich's ataxia.

Swiss oncology firm Veraxa Biotech is set to go public in the US through a merger with Voyager Acquisition Corp, a healthcare ...

The expiration of the FDA’s paediatric priority review voucher programme is creating uncertainty for rare disease drug ...

EditCo Bio has entered a licensing agreement to secure access to Promega’s protein-tagging and bioluminescent identification ...

Contraception for women has seen little change over the past 50 years, with the most prevalent contraceptive pills containing ...

Boehringer Ingelheim has signed a €500m ($572m) agreement with UK-based biotech Tessellate Bio to co-develop targeted cancer ...

Mochi Health, one of those implicated, is one of the largest telehealth providers of compounded GLP-1RAs. Eli Lilly maintains ...

ConcertAI has announced an agreement with Bayer that allows the latter to utilise its Translational360 and AI SaaS solutions.